Search

everythinglearnresearchcommunity

for

Search:↓

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Scientists made a mouse that can be made to lose hair and then grow it back.

Teledermatology is highly accurate for diagnosing inflammatory skin conditions.

AGA affects many, progresses differently, and early treatment is crucial.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Some people may temporarily lose more hair in certain areas after a hair transplant.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Allergic scalp reactions can cause temporary hair loss.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

Telogen effluvium is a hair loss condition that can be treated with medications like minoxidil.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Telogen effluvium is a condition where hair falls out due to various factors like illness, stress, or nutrient deficiency.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.